As the Oct. 31 deadline for Britain to leave the EU approaches, health professionals are warning that shortages of some medicines could worsen in Europe in the event of a no-deal Brexit.
Britain’s food and drink lobby last week said that the country would experience shortages of some fresh foods if there is a disorderly no-deal Brexit.
Pharmaceutical companies have expressed similar concerns about medicines, and some have reserved air freight capacity to fly in supplies if needed. .
However, the impact on medical supplies will also be felt beyond Britain. About 45 million packs of medicines are shipped from Britain to the rest of the bloc every month, in trade worth nearly ￡12 billion (US$14.5 billion) in 2016, a British parliament report said.
Experts say some disruption is inevitable if Britain leaves the EU without a deal. British Prime Minister Boris Johnson has said he will lead his country out of the EU on Oct. 31 without a deal if the bloc refuses to negotiate a new divorce agreement.
Some drugs might not have the required regulatory approval by then to continue being brought in from Britain. About 1 billion packs go in one direction or the other each year, industry data show.
Increased customs controls at ports and other borders between Britain and the EU could also disrupt supplies of drugs and the chemical compounds needed to produce them, regulators and industry representatives say.
“Despite intensive preparation by industry for every scenario, a no-deal Brexit risks disruption to the supply of medicines” throughout the EU, European Federation of Pharmaceutical Industries and Associations communications director Andy Powrie-Smith said.
The EU drugs regulator, the European Medicines Agency (EMA), said the bloc is well prepared for Brexit and has finalized authorisations for nearly all the 400 drugs under its watch that required further clearing because of Britain’s impending departure.
However, authorization is pending for three medicines that need EU-wide licences, an EMA official said without identifying them.
Other essential medicines could also be blocked because of supervisory hurdles because of Brexit, EMA data show.
The agency is the only body that can authorize sales in the 28-country EU of new drugs to treat the most common and serious diseases, including cancer, diabetes and flu.
Many other medicines authorized at national level could also be at risk. Nearly 6,000 of these drugs need to go through a new licensing process after Brexit.
The EMA official said the agency did not have “a full picture” of the situation in all EU states for nationally authorized medicines.
The Netherlands in February said that 50 “critical” drugs were at risk of shortages in the event of a no-deal Brexit.
Concerns about most of those drugs have since been resolved, a spokesman for the Dutch Ministry of Health, Welfare and Sport said, but problems could arise for less essential medicines.
In a report in June, the European Commission included medicines and medical devices in a list of sectors for which “continued and particular vigilance” was needed.
Many EU states already face shortages of some medicines because of problems with production, regulators or distribution.
A survey of 21 European countries showed that all of them experienced shortages of medicines last year, said Pharmaceutical Group of the EU, a pharmacists’ trade body. Vaccines were among the drugs most frequently cited as being in short supply.
Britain will need to authorize hundreds of new medicines on sale now only thanks to EU-wide registrations. It imports about 37 million medicine packs every month from the EU, industry figures show.
‘OBVIOUS DIFFERENCE’: The Wuhan Institute of Virology has been researching bat coronaviruses to trace the SARS pathogen, which is 80 percent similar to SARS-CoV-2 The Chinese virology institute in the city where COVID-19 first emerged has three live strains of bat coronavirus on-site, but none match the new contagion wreaking havoc around the world, its director has said. Scientists think COVID-19 — which first emerged in Wuhan and has killed more than 340,000 people worldwide — originated in bats and could have been transmitted to people via another mammal. However, the director of the Wuhan Institute of Virology told state broadcaster China Global Television Network that claims made by US President Donald Trump and others that the novel coronavirus could have escaped from the facility were
HUMAN RIGHTS ABUSES? An institute of the Chinese Ministry of Public Security and a company are to be sanctioned over ‘human rights violations and abuses’ The US Department of Commerce on Friday said that it would sanction a Chinese government institute and eight companies over alleged human rights abuses against Uighurs and other minorities in China’s western Xinjiang region. “These nine parties are complicit in human rights violations and abuses committed in China’s campaign of repression, mass arbitrary detention, forced labor and high-technology surveillance against Uighurs, ethnic Kazakhs and other members of Muslim minority groups in the Xinjiang Uighur Autonomous Region,” the department said in a statement. The Chinese Ministry of Public Security’s Institute of Forensic Science and Aksu Huafu Textiles Co are to be sanctioned “for
SPACE RACE: The China Aerospace Science and Technology Corp mission aims to land a robotic rover and put a probe into orbit around the planet China is targeting a July launch for its ambitious Mars mission, which includes landing a remote-controlled robot on the surface of the Red Planet, the company in charge of the project has said. Beijing has invested billions of dollars in its space program in an effort to catch up with its rival, the US, and affirm its status as a major world power. The Mars mission is among a number of new space projects China is pursuing, including putting Chinese astronauts on the moon and having a space station by 2022. Beijing had been planning the Mars mission for some time this year,
Former US vice president Joe Biden on Friday said he “should not have been so cavalier” after he told a radio host that African Americans who back US President Donald Trump “ain’t black.” In a call with the US Black Chamber of Commerce that was added to his public schedule, Biden said he would never “take the African American community for granted.” “I shouldn’t have been such a wise guy,” Biden said. “No one should have to vote for any party based on their race or religion or background.” Biden faced criticism after his comments earlier on Friday on The Breakfast Club, a